| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/30/2003 | EP0941067B1 Stable glassy state powder formulations |
| 07/30/2003 | EP0910376B1 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 07/30/2003 | EP0859628B1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 07/30/2003 | EP0837694B1 Leptospira membrane proteins |
| 07/30/2003 | EP0833923B1 Immunogenic construct, process for its preparation and use as a vaccine |
| 07/30/2003 | EP0779818B1 Liquid immunoglobulin formulations |
| 07/30/2003 | CN1433478A Novel colloid synthetic vectors for gene therapy |
| 07/30/2003 | CN1433474A Regulaed antigen delivery system (RADS) involving bacteria |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433471A 85Kgda neisserial antigen |
| 07/30/2003 | CN1433470A Neisserial antigenic peptides |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433465A Method for preservation of viruses and mycorplasma |
| 07/30/2003 | CN1433430A Hepatitis virus sentinel virus I (SVI) |
| 07/30/2003 | CN1433423A Mono and disaccharide derivatives |
| 07/30/2003 | CN1433322A Compositions comprising nei sseria meningitidis antigens from serogroups B and C |
| 07/30/2003 | CN1433321A Vaccine for prevention and treatment of Alzhermer's and amyloid related diseases |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/30/2003 | CN1432408A Prepn process of cow mammitis vaccine |
| 07/30/2003 | CN1432407A Method of obtaining body's safe high fever and relevant clinical parameters with malarial parasite |
| 07/30/2003 | CN1116414C Animal's castration vaccine gene and gene engineering body |
| 07/30/2003 | CN1116104C Method capable of scale preserving bioactivity matter by drying |
| 07/30/2003 | CN1116077C Methicine for preventing and curing malignant tumor |
| 07/30/2003 | CN1116076C Compisition for prevention and treatment of helminth infections |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600019 Polypeptides and nucleic acids encoding same |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6600012 Lipid-modified muc-1 derivatives |
| 07/29/2003 | US6599912 Methods and compositions for modulating cell proliferation and cell death |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599710 Treatment of autoimmune disease |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599510 Abundant extracellular products and methods for their production and use |
| 07/29/2003 | US6599509 Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases |
| 07/29/2003 | US6599502 Intracellular delivery vehicles |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | CA2272417C Adjuvant for transcutaneous immunization |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/29/2003 | CA2134092C Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/29/2003 | CA2097931C Salmonella vaccines |
| 07/29/2003 | CA2069481C Purified igc immunoglobulins |
| 07/29/2003 | CA2017157C Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
| 07/29/2003 | CA2012125C Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy |
| 07/29/2003 | CA1341435C Recombinant pox virus for immunization against tumor-associated antigens |
| 07/24/2003 | WO2003060468A2 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060145A2 Compositions and methods relating to pancreatic specific genes and proteins |
| 07/24/2003 | WO2003060143A2 Efficient protein expression system |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060081A2 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003060080A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 07/24/2003 | WO2003060071A2 Albumin fusion proteins |
| 07/24/2003 | WO2003059953A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 07/24/2003 | WO2003059952A1 Bispecific antibody dna constructs for intramuscular administration |
| 07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | WO2003059949A2 A protein that mediates angiogenesis and tumour growth inhibition, its cdna, alone or in complex with an expression vector |
| 07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059395A2 Antisense compounds directed against human csf-1 |
| 07/24/2003 | WO2003059387A2 Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis |
| 07/24/2003 | WO2003059386A2 Prion protein carrier-conjugates |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059384A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 07/24/2003 | WO2003059383A1 Brucellosis vaccine composition comprising poly($g(e)-caprolactone) microparticles as an adjuvant |
| 07/24/2003 | WO2003059381A2 Immunogenic preparations and vaccines on the basis of mrna |
| 07/24/2003 | WO2003059380A2 Oral vaccination |
| 07/24/2003 | WO2003059379A2 Immunogenic carcinoembryonic antigen (cea) |
| 07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
| 07/24/2003 | WO2003059273A2 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | WO2003059260A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 07/24/2003 | WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | WO2003059251A2 Antibody targeting compounds |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 07/24/2003 | WO2002099057A3 Sams modifiers of the p53 pathway and methods of use |
| 07/24/2003 | WO2002062846A3 Method and apparatus for the production of antigens and uses thereof |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same |
| 07/24/2003 | WO2002030457A9 Microbes having an attenuating mutation comprising a transcription terminator |
| 07/24/2003 | WO2002022687A3 Viral chemokine-tumur antigen fusion proteins |
| 07/24/2003 | WO2002018954A3 Inhibition of cmv infection and dissemination |
| 07/24/2003 | WO2002011758A8 Vaccine against the influenza virus and method for producing said virus vaccine |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139345 Synthetic peptides and methods for treating cancer invasion and metastasis |
| 07/24/2003 | US20030139343 Regulation of human hm74-like g protein coupled receptor |